Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company's Next Phase of Growth in Customised Interleukin Therapies ARScience Bio...

Strengthens Board with experienced industry executive, specializing in strategic planning, organizational leadership and commercial execution Broken Strin...

The landscape of both immunology and neurology therapeutics is currently undergoing a paradigm shift. Immunology therapeutics are moving beyond conventional tumo...

GELITA, a global leader in collagen protein solutions, will showcase its latest advancements in excipient technology at BIO International 2026 in San Diego (Boot...

·       Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1 ·  ...

In-vivo functional studies support lead programme selection Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive adva...

·       Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1 ·  ...

This recognition places DFE Pharma among the top 5% of companies assessed worldwide and highlights continued progress in environmental action, labour & human...

Spectronaut 21 (DIA) and SpectroMine 6 (DDA): cloud-enabled processing, increased identifications, enhanced PTM identification and site localisation confidence, ...

End-to-end safety foundation to speed case processing and enable automation Veeva Systems today announced that UCB is unifying its global safety operation...